Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 Jan;46(1):41–44. doi: 10.1136/jcp.46.1.41

Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.

J E Howarth 1, H M Waters 1, D Shanks 1, K Hyde 1, J A Yin 1, C G Geary 1, E Anastassiades 1, D Howarth 1, R Gokal 1
PMCID: PMC501111  PMID: 8432886

Abstract

AIMS: To determine the effect of concomitant azathioprine treatment on the response of patients with renal failure to treatment with subcutaneous recombinant human erythropoietin (r-HuEPO). METHODS: Two groups of patients with renal failure not receiving haemodialysis were studied. One comprised seven patients receiving erythropoietin alone, the second consisted of nine patients who were also treated with azathioprine. The haematological changes were monitored, and the functional erythropoietic response was studied by two different ferrokinetic models. One analysed the initial, the other the extended plasma iron clearance. Studies were performed before r-HuEPO treatment on all 16 patients, and repeated on 11 of these when the target haemoglobin (10-11 g/dl) was achieved and stabilised. Total erythropoiesis was determined using both techniques. Analysis of the extended plasma iron clearance also permitted calculation of both effective and ineffective erythroid activity. RESULTS: The haematological response to r-HuEPO was the same for both patient groups. Measurement of total erythropoiesis by both ferrokinetic methods showed good correlation. For those receiving long term azathioprine, the percentage ineffective erythropoiesis was high compared with that of the other patients, and remained so for as long as they continued with azathioprine. For those uncomplicated by azathioprine treatment, r-HuEPO increased levels of both effective and ineffective erythropoiesis by the same degree. A substantial reduction in ineffective erythropoiesis was shown only by those patients who either discontinued or reduced their azathioprine once they started r-HuEPO treatment. CONCLUSIONS: Azathioprine increases ineffective erythropoiesis. In this study, the r-HuEPO dose was sufficient to overcome this effect and promoted effective erythropoiesis so that the anaemia lessened. Measurement of total erythropoiesis provided limited information on the functional changes involved, differentiation of effective from ineffective erythropoiesis being necessary to define the changes after azathioprine reduction or withdrawal.

Full text

PDF
41

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson J. W., Eschbach J., Finch C. A. The kidney and erythropoiesis. Am J Med. 1968 May;44(5):725–733. doi: 10.1016/0002-9343(68)90254-4. [DOI] [PubMed] [Google Scholar]
  2. Boelaert J. R., Schurgers M. L., Matthys E. G., Belpaire F. M., Daneels R. F., De Cre M. J., Bogaert M. G. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int. 1989;9(2):95–98. [PubMed] [Google Scholar]
  3. Bommer J., Ritz E., Weinreich T., Bommer G., Ziegler T. Subcutaneous erythropoietin. Lancet. 1988 Aug 13;2(8607):406–406. doi: 10.1016/s0140-6736(88)92886-3. [DOI] [PubMed] [Google Scholar]
  4. CHAPLIN H., Jr, MOLLISON P. L. Red cell life-span in nephritis and in hepatic cirrhosis. Clin Sci. 1953 Nov;12(4):351–360. [PubMed] [Google Scholar]
  5. Cazzola M., Huebers H. A., Sayers M. H., MacPhail A. P., Eng M., Finch C. A. Transferrin saturation, plasma iron turnover, and transferrin uptake in normal humans. Blood. 1985 Oct;66(4):935–939. [PubMed] [Google Scholar]
  6. Cotes P. M., Pippard M. J., Reid C. D., Winearls C. G., Oliver D. O., Royston J. P. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. Q J Med. 1989 Feb;70(262):113–137. [PubMed] [Google Scholar]
  7. Eaves C. J., Eaves A. C. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood. 1978 Dec;52(6):1196–1210. [PubMed] [Google Scholar]
  8. Eschbach J. W., Adamson J. W. Anemia of end-stage renal disease (ESRD). Kidney Int. 1985 Jul;28(1):1–5. doi: 10.1038/ki.1985.109. [DOI] [PubMed] [Google Scholar]
  9. Eschbach J. W., Jr, Funk D., Adamson J., Kuhn I., Scribner B. H., Finch C. A. Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med. 1967 Mar 23;276(12):653–658. doi: 10.1056/NEJM196703232761202. [DOI] [PubMed] [Google Scholar]
  10. Eschbach J. W., Kelly M. R., Haley N. R., Abels R. I., Adamson J. W. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med. 1989 Jul 20;321(3):158–163. doi: 10.1056/NEJM198907203210305. [DOI] [PubMed] [Google Scholar]
  11. Hughes R. T., Cotes P. M., Pippard M. J., Stevens J. M., Oliver D. O., Winearls C. G., Royston J. P. Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment. Br J Haematol. 1990 Jun;75(2):268–273. doi: 10.1111/j.1365-2141.1990.tb02661.x. [DOI] [PubMed] [Google Scholar]
  12. Jacobs K., Shoemaker C., Rudersdorf R., Neill S. D., Kaufman R. J., Mufson A., Seehra J., Jones S. S., Hewick R., Fritsch E. F. Isolation and characterization of genomic and cDNA clones of human erythropoietin. 1985 Feb 28-Mar 6Nature. 313(6005):806–810. doi: 10.1038/313806a0. [DOI] [PubMed] [Google Scholar]
  13. Lin F. K., Suggs S., Lin C. H., Browne J. K., Smalling R., Egrie J. C., Chen K. K., Fox G. M., Martin F., Stabinsky Z. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7580–7584. doi: 10.1073/pnas.82.22.7580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Macdougall I. C., Cavill I., Davies M. E., Hutton R. D., Coles G. A., Williams J. D. Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients. Contrib Nephrol. 1989;76:219–226. doi: 10.1159/000417898. [DOI] [PubMed] [Google Scholar]
  15. Macdougall I. C., Davies M. E., Hutton R. D., Cavill I., Lewis N. P., Coles G. A., Williams J. D. The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin. Nephrol Dial Transplant. 1990;5(11):950–955. doi: 10.1093/ndt/5.11.950. [DOI] [PubMed] [Google Scholar]
  16. McGonigle R. J., Wallin J. D., Shadduck R. K., Fisher J. W. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 1984 Feb;25(2):437–444. doi: 10.1038/ki.1984.36. [DOI] [PubMed] [Google Scholar]
  17. Ricketts C., Jacobs A., Cavill I. Ferrokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell lifespan using 59Fe. Br J Haematol. 1975 Sep;31(1):65–75. doi: 10.1111/j.1365-2141.1975.tb00833.x. [DOI] [PubMed] [Google Scholar]
  18. Standard techniques for the measurement of red-cell and plasma volume. A report by the International Committee for Standardization in Hematology (ICSH): Panel on Diagnostic Applications of Radioisotopes in Haematology. Br J Haematol. 1973 Dec;25(6):801–814. [PubMed] [Google Scholar]
  19. Stevens J. M., Strong C. A., Oliver D. O., Winearls C. G., Cotes P. M. Subcutaneous erythropoietin and peritoneal dialysis. Lancet. 1989 Jun 17;1(8651):1388–1389. doi: 10.1016/s0140-6736(89)92832-8. [DOI] [PubMed] [Google Scholar]
  20. Wallner S. F., Vautrin R. M. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J Lab Clin Med. 1981 Feb;97(2):170–178. [PubMed] [Google Scholar]
  21. Winearls C. G., Oliver D. O., Pippard M. J., Reid C., Downing M. R., Cotes P. M. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986 Nov 22;2(8517):1175–1178. doi: 10.1016/s0140-6736(86)92192-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES